| |
|
|
| |
Injectable Drug Delivery
Drugs, Devices, Targets, Therapeutics and
Forecasts
|
Publication: January 2012
Product Code: KDJ558F
|
The past decade has seen a dramatic shift in terms of the
types of approved injectable drugs, the diseases they
target, and the devices used to deliver them. This shift has
fostered change on several levels of the healthcare sector.
The injectable drug segment has seen a marked increase in
the level of drug/device integration, as prefilled syringes
and specialized injection devices proliferate in response to
safety and economic challenges posed by recombinant protein
drugs, while administration of injectables has moved
increasingly from practitioner offices and healthcare
facilities to patient homes. This report examines the key
therapeutic, product, market and regulatory factors for
injectable drugs across ten major disease and therapeutic
classes, providing essential insight and forecasts into the
implications of this evolving landscape. |
|
Highlights |
· Analyzes and evaluates
the shifting landscape for injectable drug delivery and
assesses the market impact of new and emerging
injectable drug products by therapeutic indication
· Analyzes syringe and
injector device designs, feature/functionality, product
branding, competing technologies and market development
issues
· Provides detailed
descriptions of key injectable drug therapeutic market
segments, market demographics, and business strategies
· Forecasts Injectable
drug product demand by indication and therapy to 2016
· Profiles leading injection
device companies, their product development
activities, business strategies, and corporate
alliances and affiliations
|
|
Summary of Contents |
Executive Summary
Injectable Drugs – The
Market Opportunity
The Evolving Drug
Therapeutics Landscape
Injectable Drug Demand
Drivers
Diseases and Indications
Patient
Demographics
Developing Economies
Market
Factors
Managed Care and Healthcare Costs
Regulations and Regulatory Sentiment
Technology
Drivers
Drug Stability
Device Design &
Technology
Patient and Care-giver Sentiment
Self-Administration and Patient-friendly Features
Commercial Injection Devices
Syringes
Traditional Disposables
Prefilled Syringes
Glass
Plastic
Prefillable Safety Syringes
Autoinjectors
Safety Syringes
Pen Injectors
Needle-free Injectors
Novel Injection Devices
Injectable Drug Therapeutics – Technology
Factors
Formulation Factors
Biological Drug
Stability
Sustained Release Formulations
Lyophilization and Reconstitution
Growth of
Prefilled Syringes
Partnerships and Alliances
PFS Manufacturing
Fill-and-Finish Operations
Device Selection Factors
Drug-Device
Compatibility
Luer vs Fixed Needle
Customized
injection Devices
Injectable Drug
Therapeutics – Market Factors
Regulatory Factors
and Issues
FDA Regulations
FDA Guidance
Regulating Combination Products
Sharps
Legislations
Growth and Diversity of Safety
Syringes
Sharps Disposal
Clinical Trial
Factors
Managed Care and Healthcare Economics
Injectable Drug Therapeutics – Segment
Assessments and Forecasts
Anemia
Anticoagulants
Growth Hormone Deficiency
Hepatitis
Inflammatory Autoimmune Diseases
Osteoporosis
Multiple Sclerosis
Reproductive
Medicine
Profiles of Market Participants
|
|
|
|
|
